Business Context and Reporting Period
Company: Achieve Life Sciences, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 12, 2020
Reporting Period: Third quarter ended September 30, 2020
Context: The filing serves to announce the Company's financial results for the third quarter of 2020 via a press release furnished as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific numerical data. It references a press release (Exhibit 99.1) for details on revenue, profit, cash flow, margins, debt, and liquidity. Consequently, the filing text does not provide a clear value for any specific financial metric.
Material Changes
No material changes or comparative financial data are disclosed within the text of this specific filing. The document solely indicates that results for the period ended September 30, 2020, have been announced.
Guidance, Outlook, and Risks
The text contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. It explicitly states that the information in Item 2.02 and Exhibit 99.1 is furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 12, 2020) for actual revenue, net income, and cash flow figures.
- Verify the Company's liquidity position and debt levels in the full press release or subsequent 10-Q filing.
- Confirm any operational updates or strategic shifts mentioned in the referenced press release.
- Note that the 8-K text itself does not incorporate the financial data by reference for liability purposes under Section 18.